Login / Signup

Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' reply.

Raphael MohrFrank TackeChristoph Roderburg
Published in: Alimentary pharmacology & therapeutics (2024)
Keyphrases
  • phase iii
  • study protocol
  • clinical trial
  • phase ii
  • open label
  • finite element analysis
  • double blind
  • placebo controlled